Cargando…
Combination Effects of Peramivir and Favipiravir against Oseltamivir-Resistant 2009 Pandemic Influenza A(H1N1) Infection in Mice
Antiviral drugs are being used for therapeutic purposes against influenza illness in humans. However, antiviral-resistant variants often nullify the effectiveness of antivirals. Combined medications, as seen in the treatment of cancers and other infectious diseases, have been suggested as an option...
Autores principales: | Park, Sehee, Kim, Jin Il, Lee, Ilseob, Lee, Sangmoo, Hwang, Min-Woong, Bae, Joon-Yong, Heo, Jun, Kim, Donghwan, Jang, Seok-Il, Kim, Hyejin, Cheong, Hee Jin, Song, Jin-Won, Song, Ki-Joon, Baek, Luck Ju, Park, Man-Seong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4081560/ https://www.ncbi.nlm.nih.gov/pubmed/24992479 http://dx.doi.org/10.1371/journal.pone.0101325 |
Ejemplares similares
-
Phylogenetic Analysis of a Swine Influenza A(H3N2) Virus Isolated in Korea in 2012
por: Kim, Jin Il, et al.
Publicado: (2014) -
Surface glycoproteins determine the feature of the 2009 pandemic H1N1 virus
por: Kim, Jin Il, et al.
Publicado: (2012) -
Clinical Effectiveness of Intravenous Peramivir versus Oseltamivir for the Treatment of Influenza in Hospitalized Patients
por: Lee, Jin Seo, et al.
Publicado: (2020) -
Inhibition of Pseudomonas aeruginosa with a recombinant RNA-based viral vector expressing human β-defensin 4
por: Park, Sehee, et al.
Publicado: (2014) -
Oseltamivir/peramivir: Lack of efficacy: case report
Publicado: (2020)